Sort
82,697 grants matching “vaccine development”
DESIGN OF NOVEL IMMUNOGENS AND ADJUVANTS FOR HIV VACCINE
$1,004,634Duke University · P01 · FY2003 · AI
AT191: An inhaled & precision RNA therapeutic with pan-variant SARS-CoV-2 efficacy
$1,004,473Ariel Weinberger · Autonomous Therapeutics, Inc. · R44 · FY2025 · AI
Project 1: Immunization strategies to elicit broadly neutralizing antibodies against HIV-1
$1,004,305Pamela J Bjorkman · California Institute Of Technology · P01 · FY2022 · AI
Evaluation of Smoke-Free Housing Policy Impacts on Tobacco Smoke Exposure and Health Outcomes
$1,004,207Lorna Thorpe · New York University School Of Medicine · R01 · FY2021 · CA
DEVELOPMENT OF A PRIMATE GENOMIC RESOURCE
$1,004,205Michael G Katze · University Of Washington · R24 · FY2010 · RR
Advanced Development of a Vaccine for Acute Flaccid Myelitis Associated with Enterovirus D68
$1,004,130Dinja Oosterhoff · Intravacc B.V. · N01 · FY2025 · AI
Mesothelin-targeted immunotoxins in Pancreatic Cancer
$1,004,043Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
$1,003,946Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Vanderbilt HIV Clinical Trials Unit
$1,003,759David W Haas · Vanderbilt University Medical Center · UM1 · FY2017 · AI
PROTOZOAN PURINE PHOSPHORIBOSYLTRANSFERASES AS TARGETS TO TREAT MALARIA, AFRICAN TRYPANOSOMIASIS AND CHAGAS'S DISEASE
$1,003,662Thomas Meek · Texas A&M Agrilife Research · R01 · FY2021 · AI
T CELL MEMORY GENERATION AND FUNCTION
$1,003,427Trudeau Institute, Inc. · P01 · FY2001 · AI
Antibody effector function in protection against HIV-1
$1,003,228Dennis R. Burton · Scripps Research Institute, The · R37 · FY2012 · AI
Discovery and Translational Core Services
$1,003,056Gerald A Beltz · Harvard Medical School · U19 · FY2018 · AI
Autoimmunity: Mechanisms of Unresponsiveness
$1,002,938Charles Garrison Fathman · Stanford University · P01 · FY2007 · AI
DISSEMINATED TUBERCULOSIS IN HIV INFECTION
$1,002,644Dartmouth College · R01 · FY2001 · AI
Autoimmunity: Mechanisms of Unresponsiveness
$1,002,489Stanford University · P01 · FY2005 · AI
Role of Regulatory T Cells in Parasitic Infections
$1,002,437Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Quick and Accurate Measurements of HIV Broadly Neutralizing Antibody Susceptibility
$1,002,428Xueling Wu · Columbia University Health Sciences · R61 · FY2023 · AI
Quick and Accurate Measurements of HIV Broadly Neutralizing Antibody Susceptibility
$1,002,428Masahiro Yamashita · Columbia University Health Sciences · R61 · FY2024 · AI
Living in the post-Zika world: Impact of interactions between dengue and Zika viruses on diagnostics, antibody dynamics, and correlates of disease risk
$1,002,425Eva Harris · University Of California Berkeley · U01 · FY2023 · AI
Time-lapse Flow Cytometry for Kinetic Profiling of T-Cell Function
$1,002,340Sheldon J.j. Kwok · Lase Innovation Inc. · R44 · FY2023 · CA
ENTERIC PATHOGENS - MUCOSAL RESEARCH UNIT
$1,002,195University Of Maryland Baltimore · N01 · FY2000 · AI
Advancing Transplantation Outcomes in Children
$1,002,068David Michael Briscoe · Boston Children'S Hospital · U01 · FY2024 · AI
A Novel Immunological-Directed Live Biotherapy Product for Treating Ulcerative Colitis
$1,001,952Gary Fanger · Rise Therapeutics, Llc · R44 · FY2023 · DK
Task A63: Evaluation of therapeutics and vaccines in mouse models of dengue virus
$1,001,923David Beasley · University Of Texas Med Br Galveston · N01 · FY2022 · AI